Clinical Trials
246 trialsTrial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
University of California, San Diego
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
University of Chicago
MEDINDUCTION
Gustave Roussy, Cancer Campus, Grand Paris
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
Pfizer
AcceleRET-Lung
Hoffmann-La Roche
DeintensiF
Insel Gruppe AG, University Hospital Bern
PORTICO
Luzerner Kantonsspital
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
EMD Serono
MACS
University of Wisconsin, Madison
This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
Boehringer Ingelheim
OPPIDOM
Institut de cancérologie Strasbourg Europe
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Takeda
NIRADO
Gustave Roussy, Cancer Campus, Grand Paris
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
Bolt Biotherapeutics, Inc.
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
PAVO
Tempus AI
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
EMD Serono
ARMOR
University of Pennsylvania
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
Bolt Biotherapeutics, Inc.
BelieveIT-201
Ascendis Pharma A/S
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
Icahn School of Medicine at Mount Sinai
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
University of California, San Diego
Unilateral Neck Radiotherapy in Head and Neck Cancer
AHS Cancer Control Alberta
DOLPHIN-VIVO
University of Exeter
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer
Thomas Jefferson University
A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Elevation Oncology
3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy
M.D. Anderson Cancer Center
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Henry Ford Health System
Study of ALE.C04 in Patients With Head and Neck Cancer
Alentis Therapeutics AG
MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer
Wake Forest University Health Sciences
The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy
OHSU Knight Cancer Institute
RAREST-02
University Hospital Schleswig-Holstein
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Aminex Therapeutics, Inc.
EMST and Swallowing in Long-Term Survivors of HNCA
University of Wisconsin, Milwaukee
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Washington University School of Medicine
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Atara Biotherapeutics
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases
Rakuten Medical, Inc.
PDL1x41BB
Inhibrx Biosciences, Inc
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Novartis
INDUCE-4
GlaxoSmithKline
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
RifRam
The Netherlands Cancer Institute
INDUCE-3
GlaxoSmithKline